HypertensionNCT07170397
Effects of Laser Acupuncture Treatment in Hypertension Haemodialysis Patients
A study testing Acupuncture Laser Therapy in people with Hypertension, run by Sinai University at 2 sites in Egypt.
Trial summary
The purpose of this study is to find the effect of acupuncture laser therapy on Blood Pressure in Hypertension Haemodialysis Patients Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Hypertension
- What is being tested?
- Acupuncture Laser Therapy
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 2 sitesEgypt
- Study dates
- 3 Aug 2026to 1 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- sixty hemodialysis patients undergoing physical therapy treatments will participate in the study. Their mean age will range from (18-65) years old
Who cannot join
- a failure to take part in more than three light therapy sessions; a kidney transplant; and death
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt2 sites
Cairo university- Faculity of physical therapy
Cairo, Cairo Governorate, 11562
Shimaa Galal Elsayed, lecturer, +20-100-311-9152, shimaagalal1986@gmail.com
Sinai university- Faculity of physical therapy
El Arish, Sinai, 11562
About this study
Official title: Effects of a Single Session of Laser Acupuncture Treatment on Blood Pressure and in Hypertension Haemodialysis Patients
The purpose of this study is to find the effect of acupuncture laser therapy on Blood Pressure in Hypertension Haemodialysis Patients
Read the detailed description
In patients with end-stage renal disease (ESRD) receiving dialysis, elevated blood pressure is common and poorly controlled in general. Although volume overload and sodium retention appear to be the main pathogenic mechanism of hypertension in this population, other factors such as increased arterial stiffness, activation of renin-angiotensin-aldosterone system, sleep apnea, activation of sympathetic nervous system, and use of recombinant erythropoietin may be also involved. Acupuncture laser therapy, which uses low-level laser treatment at specific acupuncture points, has shown promise in reducing blood pressure without invasive procedures. However, its specific efficacy in hemodialysis patients remains underexplored, necessitating this research
- Conditions
- Hypertension
- Being tested
- Acupuncture Laser Therapy
- Keywords
- laser Acupuncture Treatment, Blood Pressure, Hypertension Haemodialysis Patients
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Acupuncture Laser TherapyDevice
Application of low-level laser therapy to patients with chronic kidney disease to evaluate its effects on pain, circulation, and functional outcomes
| Study group | Role | What they receive |
|---|---|---|
| Efficacy of of Acupuncture Laser Therapy on Hemodialysis | Active comparator | Patients receive Acupuncture Laser Therapy Receives: Device: Acupuncture Laser Therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in systolic and diastolic blood pressure
Blood pressure will be measured using a calibrated sphygmomanometer
Measured: Baseline and after 4 weeks of low-level laser therapy
Blood pressure
Blood pressure will be measured using a calibrated sphygmomanometer
Measured: Baseline and after 4 weeks of low-level laser therapy
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Sep 2025
- Study start3 Aug 2026 (estimated)
- Primary completion1 Oct 2027 (estimated)
- Study completion1 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- This expected prospective randomized control trial study will involve 60 haemodialysis patients with hypertension. The patients in the experimental group (E) will subject, medical treatment besides acupuncture laser therapy. Medical treatment will be used in the control group (C). Sleep quality and Blood pressure measurement will be used in the assessment of outcome
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sinai University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Amany Gomaa Atiaa, Sinai University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07170397
- Sponsor's protocol ID
- SU.REC.2025 (60 H)
- Other IDs
- SU.REC.2025 (60 H)
- Status last verified
- Aug 2026
- First submitted
- 5 Sep 2025
- Last updated
- 4 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared
Study at a glance
From the registry record, last updated by the sponsor on 4 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of a Single Session of Laser Acupuncture Treatment on Blood Pressure and in Hypertension Haemodialysis Patients
- ClinicalTrials.gov ID
- NCT07170397
- Acronym / sponsor ID
- SU.REC.2025 (60 H)
- Conditions
- Hypertension
- Keywords
- laser Acupuncture Treatment, Blood Pressure, Hypertension Haemodialysis Patients
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Sinai UniversityUniversity, hospital or other
- Study start
- 3 Aug 2026 (estimated)
- Primary completion
- 1 Oct 2027 (estimated)
- Study completion
- 1 Dec 2027 (estimated)
- First posted
- 12 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to find the effect of acupuncture laser therapy on Blood Pressure in Hypertension Haemodialysis Patients
Detailed description
In patients with end-stage renal disease (ESRD) receiving dialysis, elevated blood pressure is common and poorly controlled in general. Although volume overload and sodium retention appear to be the main pathogenic mechanism of hypertension in this population, other factors such as increased arterial stiffness, activation of renin-angiotensin-aldosterone system, sleep apnea, activation of sympathetic nervous system, and use of recombinant erythropoietin may be also involved. Acupuncture laser therapy, which uses low-level laser treatment at specific acupuncture points, has shown promise in reducing blood pressure without invasive procedures. However, its specific efficacy in hemodialysis patients remains underexplored, necessitating this research
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- This expected prospective randomized control trial study will involve 60 haemodialysis patients with hypertension. The patients in the experimental group (E) will subject, medical treatment besides acupuncture laser therapy. Medical treatment will be used in the control group (C). Sleep quality and Blood pressure measurement will be used in the assessment of outcome
| Arm | Type | Receives |
|---|---|---|
| Efficacy of of Acupuncture Laser Therapy on Hemodialysis | Active comparator | Device: Acupuncture Laser TherapyPatients receive Acupuncture Laser Therapy |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- sixty hemodialysis patients undergoing physical therapy treatments will participate in the study. Their mean age will range from (18-65) years old
Key exclusion criteria (1 listed)
- a failure to take part in more than three light therapy sessions; a kidney transplant; and death
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Acupuncture Laser TherapyApplication of low-level laser therapy to patients with chronic kidney disease to evaluate its effects on pain, circulation, and functional outcomes | Device | Efficacy of of Acupuncture Laser Therapy on Hemodialysis |
Primary outcome
Change in systolic and diastolic blood pressure
Time frame: Baseline and after 4 weeks of low-level laser therapy
Blood pressure will be measured using a calibrated sphygmomanometer
Blood pressure
Time frame: Baseline and after 4 weeks of low-level laser therapy
Blood pressure will be measured using a calibrated sphygmomanometer
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Aug 2026.
- This randomized controlled trial will investigate the effects of low-level laser therapy (LLLT) on blood pressure, functional capacity, and quality of life in patients with chronic kidney disease undergoing hemodialysis. Participants will be randomly assLink provided by the sponsor.
- Individual participant dataSharing planned: No. Individual participant data will not be shared
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Acupuncture Laser Therapy in people with Hypertension, run by Sinai University at 2 sites in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 4 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Shimaa Galal Elsayed, lecturer (+20-100-311-9152, shimaagalal1986@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in systolic and diastolic blood pressure (time frame: Baseline and after 4 weeks of low-level laser therapy). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2026.